Bangsberg DR - Search Results

1

Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.

Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Gardner EM, et al. Among authors: bangsberg dr. AIDS. 2009 Jun 1;23(9):1035-46. doi: 10.1097/QAD.0b013e32832ba8ec. AIDS. 2009. PMID: 19381075 Free PMC article. Review.

2

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

3

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Bangsberg DR, et al. AIDS. 2001 Jun 15;15(9):1181-3. doi: 10.1097/00002030-200106150-00015. AIDS. 2001. PMID: 11416722 No abstract available.

4

Adherence is not a barrier to successful antiretroviral therapy in South Africa.

Orrell C, Bangsberg DR, Badri M, Wood R. Orrell C, et al. Among authors: bangsberg dr. AIDS. 2003 Jun 13;17(9):1369-75. doi: 10.1097/00002030-200306130-00011. AIDS. 2003. PMID: 12799558 Clinical Trial.

5

Doubts about DOT: antiretroviral therapy for resource-poor countries.

Liechty CA, Bangsberg DR. Liechty CA, et al. Among authors: bangsberg dr. AIDS. 2003 Jun 13;17(9):1383-7. doi: 10.1097/00002030-200306130-00013. AIDS. 2003. PMID: 12799560

6

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. Bangsberg DR, et al. AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011. AIDS. 2003. PMID: 12960825

7

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.

Wood E, Montaner JS, Bangsberg DR, Tyndall MW, Strathdee SA, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: bangsberg dr. AIDS. 2003 Nov 21;17(17):2419-27. doi: 10.1097/00002030-200311210-00003. AIDS. 2003. PMID: 14600512 Review. No abstract available.

8

Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. Liechty CA, et al. Among authors: bangsberg dr. AIDS. 2004 Jan 2;18(1):127-9. doi: 10.1097/00002030-200401020-00017. AIDS. 2004. PMID: 15090840

9

Adherence without access to antiretroviral therapy in sub-Saharan Africa?

Bangsberg DR, Ware N, Simoni JM. Bangsberg DR, et al. AIDS. 2006 Jan 2;20(1):140-1; author reply 141-2. doi: 10.1097/01.aids.0000196168.50303.31. AIDS. 2006. PMID: 16327340 No abstract available.

10

Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.

Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, Schechter MT, Hogg RS, Montaner JS. Braitstein P, et al. Among authors: bangsberg dr. AIDS. 2006 Feb 14;20(3):323-31. doi: 10.1097/01.aids.0000198091.70325.f4. AIDS. 2006. PMID: 16439865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters